{"id":"https://openalex.org/W2967658902","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.2567","title":"A novel non-HLA-restricted cellular immune assay for monitoring patient (pt) response to targeted immunotherapeutics","display_name":"A novel non-HLA-restricted cellular immune assay for monitoring patient (pt) response to targeted immunotherapeutics","publication_year":2006,"publication_date":"2006-06-20","ids":{"openalex":"https://openalex.org/W2967658902","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.2567","mag":"2967658902"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2006.24.18_suppl.2567","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.2567","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.24.18_suppl.2567","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111990897","display_name":"Kelledy H. Manson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Manson","raw_affiliation_strings":["Therion Biologics Corporation, Cambridge, MA; Lombardi Cancer Center, Washington, DC; New York Presbyterian Hospital/Columbia, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therion Biologics Corporation, Cambridge, MA; Lombardi Cancer Center, Washington, DC; New York Presbyterian Hospital/Columbia, New York, NY","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069589152","display_name":"K. E. Dolan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. E. Dolan","raw_affiliation_strings":["Therion Biologics Corporation, Cambridge, MA; Lombardi Cancer Center, Washington, DC; New York Presbyterian Hospital/Columbia, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therion Biologics Corporation, Cambridge, MA; Lombardi Cancer Center, Washington, DC; New York Presbyterian Hospital/Columbia, New York, NY","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Marshall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Marshall","raw_affiliation_strings":["Therion Biologics Corporation, Cambridge, MA; Lombardi Cancer Center, Washington, DC; New York Presbyterian Hospital/Columbia, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therion Biologics Corporation, Cambridge, MA; Lombardi Cancer Center, Washington, DC; New York Presbyterian Hospital/Columbia, New York, NY","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090739964","display_name":"Howard L. Kaufman","orcid":"https://orcid.org/0000-0003-1131-004X","observed_orcids":["https://orcid.org/0000-0003-1131-004X","https://orcid.org/0000-0003-3538-4166"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Kaufman","raw_affiliation_strings":["Therion Biologics Corporation, Cambridge, MA; Lombardi Cancer Center, Washington, DC; New York Presbyterian Hospital/Columbia, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therion Biologics Corporation, Cambridge, MA; Lombardi Cancer Center, Washington, DC; New York Presbyterian Hospital/Columbia, New York, NY","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089681670","display_name":"Gail P. Mazzara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. P. Mazzara","raw_affiliation_strings":["Therion Biologics Corporation, Cambridge, MA; Lombardi Cancer Center, Washington, DC; New York Presbyterian Hospital/Columbia, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therion Biologics Corporation, Cambridge, MA; Lombardi Cancer Center, Washington, DC; New York Presbyterian Hospital/Columbia, New York, NY","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052111462","display_name":"Thomas J. Schuetz","orcid":"https://orcid.org/0000-0002-6027-7912","observed_orcids":["https://orcid.org/0000-0002-6027-7912"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. J. Schuetz","raw_affiliation_strings":["Therion Biologics Corporation, Cambridge, MA; Lombardi Cancer Center, Washington, DC; New York Presbyterian Hospital/Columbia, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Therion Biologics Corporation, Cambridge, MA; Lombardi Cancer Center, Washington, DC; New York Presbyterian Hospital/Columbia, New York, NY","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"18_suppl","first_page":"2567","last_page":"2567"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/therapeutic-cancer-vaccines","display_name":"therapeutic cancer vaccines","score":0.6990000009536743},{"id":"https://openalex.org/keywords/interferon-gamma-production","display_name":"IFN-gamma production","score":0.5149999856948853},{"id":"https://openalex.org/keywords/cea","display_name":"CEA","score":0.6769999861717224},{"id":"https://openalex.org/keywords/muc1","display_name":"MUC1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.7689999938011169},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.4569999873638153},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.7110000252723694},{"id":"https://openalex.org/keywords/immune-response-monitoring","display_name":"immune response monitoring","score":0.5550000071525574},{"id":"https://openalex.org/keywords/costimulatory-molecules","display_name":"costimulatory molecules","score":0.6320000290870667}],"concepts":[{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.9480868577957153},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7232903838157654},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6676859855651855},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6121855974197388},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.6041681170463562},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4999713897705078},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.3858414590358734},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29773828387260437},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1390438973903656},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2006.24.18_suppl.2567","doi":"https://doi.org/10.1200/jco.2006.24.18_suppl.2567","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2006.24.18_suppl.2567","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.8600000143051147,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2277047186","https://openalex.org/W2150193997","https://openalex.org/W3009042092","https://openalex.org/W2125886382","https://openalex.org/W2017873985","https://openalex.org/W3165374934","https://openalex.org/W1534722988","https://openalex.org/W7100112551","https://openalex.org/W2059092169","https://openalex.org/W2605332661"],"abstract_inverted_index":{"2567":[0],"Background:":[1],"Many":[2],"therapeutic":[3],"cancer":[4,88,139,309],"vaccines":[5],"are":[6,279],"designed":[7],"to":[8,112,193,233,257,261,284],"elicit":[9],"T-cell":[10],"immunity.":[11],"In":[12,197],"vitro":[13],"monitoring":[14],"of":[15,23,73,82,222,243,267,324],"pt":[16],"response":[17,192,245,260,290],"is":[18,215,231],"limited":[19],"by":[20,37],"the":[21,56,165,213,228],"HLA-restriction":[22],"ELISPOT":[24],"assays.":[25],"We":[26,250],"report":[27],"a":[28,46,78,124,240,252,262,286,302,311,320],"novel,":[29,253],"non-restricted":[30,254],"assay":[31,256,295],"for":[32,168,174,185,299],"measuring":[33],"immune":[34,115,191,244,259,275,289,325],"responses":[35,326],"generated":[36],"PANVAC-VF,":[38],"which":[39,230],"comprises":[40],"2":[41,314],"recombinant":[42],"viral":[43],"vectors":[44],"in":[45,77,131,307,316],"heterologous":[47],"prime-boost":[48],"immunization":[49],"regimen.":[50],"Each":[51],"vector":[52],"contains":[53],"genes":[54],"encoding":[55],"tumor":[57],"antigens":[58],"CEA":[59,194],"and":[60,62,69,103,164,291,310],"MUC-1,":[61],"3":[63,305],"immunologic":[64],"costimulatory":[65],"molecules":[66],"B7.1,":[67],"LFA-3,":[68],"ICAM-1.":[70],"The":[71],"safety":[72],"PANVAC-VF":[74],"was":[75,144],"tested":[76],"Phase":[79,304,313],"1":[80],"study":[81,306,315],"10":[83],"pts":[84,181,270],"with":[85,146,159,182,204,246],"advanced":[86],"pancreatic":[87,308],"(ASCO":[89],"2005":[90],"abstr":[91],"2576).":[92],"Methods:":[93],"Peripheral":[94],"blood":[95,122],"mononuclear":[96],"cells":[97],"(PBMCs)":[98],"were":[99,118,129,156,172],"drawn":[100],"at":[101],"baseline":[102],"each":[104,110],"subsequent":[105],"timepoint":[106],"(\u223c2":[107],"wks":[108],"after":[109],"injection)":[111],"measure":[113],"cellular":[114,255,274],"responses.":[116],"PBMCs":[117,128,155,183],"separated":[119],"from":[120,224,301,327],"whole":[121],"over":[123],"Ficoll":[125],"gradient;":[126],"isolated":[127],"frozen":[130],"liquid":[132],"nitrogen":[133],"until":[134],"analysis.":[135],"A":[136],"monkey":[137],"breast":[138],"cell":[140],"line":[141],"(CMMT":[142],"110/C1)":[143],"infected":[145,160],"PANVAC-F":[147],"or":[148],"control":[149],"fowlpox":[150],"recombinant.":[151],"On":[152],"Day":[153],"2,":[154],"incubated":[157],"10:1":[158],"CMMT":[161],"110/C1":[162],"cells,":[163,219],"mixtures":[166],"co-cultivated":[167],"72":[169],"h.":[170],"Supernatants":[171],"assayed":[173,269],"interferon":[175,199],"\u03b3":[176,200],"production.":[177],"Results:":[178],"Of":[179],"8":[180,268],"sufficient":[184],"testing,":[186],"5":[187],"developed":[188,251,271],"an":[189,272],"antigen-specific":[190,273],"and/or":[195],"MUC-1.":[196],"general,":[198],"production":[201],"steadily":[202],"increased":[203],"repeat":[205],"boosting":[206],"immunizations.":[207],"Cellular":[208],"depletion":[209],"experiments":[210],"suggest":[211],"that":[212],"result":[214],"dependent":[216],"on":[217],"CD4+":[218],"allowing":[220],"analysis":[221,238],"samples":[223,300],"all":[225,328],"pts,":[226],"unlike":[227],"ELISPOT,":[229],"restricted":[232],"HLA-A2":[234],"peptide":[235],"presentation.":[236],"Preliminary":[237],"suggests":[239],"positive":[241],"correlation":[242,287],"overall":[247,292],"survival.":[248,293],"Conclusions:":[249],"assess":[258],"targeted":[263],"immunotherapeutic,":[264],"PANVAC-VF.":[265],"Five":[266],"response.":[276],"Pt":[277],"numbers":[278],"small,":[280],"but":[281],"there":[282],"appears":[283],"be":[285,297],"between":[288],"This":[294],"will":[296],"used":[298],"randomized":[303,312],"prostate":[317],"cancer,":[318],"generating":[319],"large":[321],"data":[322],"set":[323],"pts.":[329],"[Table:":[330],"see":[331],"text]":[332]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2019-08-22T00:00:00"}